• 1. An artificial blood vessel implanted three-dimensional microsystem for modeling transvascular migration of tumor cells?
  Xue-Ying Wang,Ying Pei,Min Xie,Zi-He Jin,Ya-Shi Xiao,Yang Wang,Li-Na Zhang,Yan Li,Wei-Hua Huang Lab Chip, 2015,15, 1178-1187
• 2. An amide probe as a selective Al3+ and Fe3+ sensor inside the HeLa and a549 cell lines: Pictet–Spengler reaction for the rapid detection of tryptophan amino acid?
  Bidyut Kumar Kundu,Rinky Singh,Ritudhwaj Tiwari,Debasis Nayak New J. Chem., 2019,43, 4867-4877
• 3. An intermolecular C–C coupling reaction of iridium complexes?
  Kathrin Kutlescha,Rhett Kempe New J. Chem., 2010,34, 1954-1960
• 4. Acetyl group orientation modulates the electronic ground-state asymmetry of the special pair in purple bacterial reaction centers
  P. K. Wawrzyniak,M. T. P. Beerepoot,H. J. M. de Groot,F. Buda Phys. Chem. Chem. Phys., 2011,13, 10270-10279
• 5. An Appraisal of pH triggered Bacitracin drug release, through composite hydrogel systems
  RabailGul,MariamMir,MurtazaNAli

Introduction to N-(2-Cyanophenyl)-N-methylmethanesulfonamide (CAS No. 1073159-70-2)

N-(2-Cyanophenyl)-N-methylmethanesulfonamide, a compound with the chemical formula C₉H₉N₂O₂S, is a significant molecule in the field of pharmaceutical chemistry and bioorganic synthesis. This compound is identified by its unique CAS number, CAS No. 1073159-70-2, which distinguishes it from other chemical entities in the database. The structural framework of this molecule incorporates a cyanophenyl group and a methylmethanesulfonamide moiety, making it a versatile intermediate in the synthesis of more complex pharmaceutical agents.

The cyanophenyl group, characterized by its electron-withdrawing properties, plays a crucial role in modulating the reactivity and electronic distribution of the molecule. This feature is particularly valuable in medicinal chemistry, where such groups are often employed to enhance binding affinity to biological targets. The presence of the cyano group also suggests potential for further functionalization, allowing chemists to tailor the molecule for specific applications.

The methylmethanesulfonamide moiety contributes to the overall polarity and solubility of N-(2-cyanophenyl)-N-methylmethanesulfonamide, making it suitable for various solvents and reaction conditions. This sulfonamide group is well-documented for its role in drug design, often serving as a pharmacophore in molecules targeting neurological and inflammatory disorders. The combination of these two functional groups in a single molecule opens up numerous possibilities for its use in synthetic chemistry and drug development.

In recent years, there has been growing interest in the development of novel sulfonamide derivatives due to their broad spectrum of biological activities. Research has demonstrated that sulfonamides can act as inhibitors of enzymes and receptors involved in pathogenic processes. For instance, studies have shown that certain sulfonamides exhibit potent anti-inflammatory and analgesic properties, making them attractive candidates for therapeutic intervention. N-(2-Cyanophenyl)-N-methylmethanesulfonamide, with its unique structural features, could potentially be explored for similar applications.

The synthesis of N-(2-cyanophenyl)-N-methylmethanesulfonamide involves multi-step organic reactions that require careful optimization to achieve high yields and purity. Common synthetic routes include nucleophilic substitution reactions followed by condensation steps to introduce the desired functional groups. Advanced techniques such as palladium-catalyzed cross-coupling reactions may also be employed to enhance selectivity and efficiency. The synthesis process highlights the importance of understanding reaction mechanisms and intermediates to fine-tune the final product's characteristics.

The pharmacological potential of N-(2-cyanophenyl)-N-methylmethanesulfonamide has been explored in several preclinical studies. These investigations have focused on its interactions with various biological targets, including enzymes and receptors relevant to human health. Preliminary findings suggest that this compound may exhibit inhibitory activity against certain enzymes involved in metabolic pathways associated with diseases such as diabetes and cancer. Additionally, its ability to cross the blood-brain barrier makes it an intriguing candidate for central nervous system disorders.

The role of computational chemistry in understanding the behavior of N-(2-cyanophenyl)-N-methylmethanesulfonamide cannot be overstated. Molecular modeling techniques allow researchers to predict how this compound will interact with biological targets at the atomic level. This information is crucial for designing experiments aimed at optimizing its pharmacological properties. Furthermore, computational methods can help identify potential side effects or toxicities before experimental testing begins, thereby saving time and resources.

In conclusion, N-(2-cyanophenyl)-N-methylmethanesulfonamide (CAS No. 1073159-70-2) is a promising compound with significant potential in pharmaceutical research and development. Its unique structural features, combined with its favorable physicochemical properties, make it an attractive candidate for further exploration. As our understanding of biological systems continues to evolve, compounds like this one will play an increasingly important role in addressing complex diseases and improving patient outcomes.

• 143937-54-6(Methanesulfonamide, N-methyl-N-(4-methylphenyl)-)
• 910486-27-0(Methanesulfonamide, N-(4-cyano-2-methylphenyl)-)
• 143937-61-5(METHANESULFONAMIDE, N-METHYL-N-(3-METHYLPHENYL)-)
• 791070-95-6(Methanesulfonamide, N-(2-cyano-3-fluorophenyl)-N-methyl-)
• 50790-29-9(2-(Methanesulfonylamino)benzonitrile)
• 869371-40-4(N-2-(aminomethyl)phenyl-N-methylmethanesulfonamide)
• 349403-35-6(N-ethyl-N-(2-methylphenyl)methanesulfonamide)
• 1088979-71-8(2-(N-methyl-N-(methanesulfonyl)amino)benzyl alcohol)
• 761432-72-8(BENZOIC ACID, 3-[(2-CYANOPHENYL)(METHYLSULFONYL)AMINO]-)
• 869371-52-8(METHANESULFONAMIDE, N-[2-(AMINOMETHYL)-3-METHYLPHENYL]-N-METHYL-)